Imagen de Portada

New treatment modalities for neovascular age-related macular degeneration

Age-related macular degeneration (AMD) is considered one of the main causes of severe vision loss in older adults. The neovascular form (nAMD) is an advanced stage, which is responsible for the most severe vision loss. Vascular endothelial growth factor (VEGF) is at present the main factor that lead...

Descripción completa

Detalles Bibliográficos
Autores Principales: Schlottmann, Patricio G, Alezzandrini, Arturo A, Zas, Marcelo, Rodriguez, Francisco J, Luna, José D, Wu, Lihteh
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: Asia-Pacific Academy of Ophthalmology 2017
Materias:
Angiogenesis inhibitor
Monoclonal antibody
Platelet derived growth factor
Vasculotropin
Antagonists and inhibitors
Clinical trial (topic)
Gene therapy
Human
Macular degeneration
Procedures
Subretinal neovascularization
Angiogenesis inhibitors
Choroidal neovascularization
Clinical trials as topic
Genetic therapy
Humans
Platelet-derived growth factor
Vascular endothelial growth factors
Amd
Neovascular
New
Treatment
Vegf
monoclonal
Antibodies
Acceso en línea:https://repository.urosario.edu.co/handle/10336/23066
https://doi.org/10.22608/APO.2017258

Internet

https://repository.urosario.edu.co/handle/10336/23066
https://doi.org/10.22608/APO.2017258

Ejemplares similares